Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
90 /100
CRITICAL RISK
Score updated Oct 13, 2026

AUTL — Autolus Therapeutics plc Dilution Risk Tracker

Track AUTL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AUTL — Get alerts when the score changes →

As of October 13, 2026, Autolus Therapeutics plc (AUTL) has a DilutionWatch DilutionScore of 90/100, rated CRITICAL dilution risk. Autolus Therapeutics plc has a market capitalization of $463.12M, 266.16M shares outstanding, 84 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $1.00B, 56.50M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
96
💰 Cash Runway
65
📊 Float Risk
100
⚠️ Warrant Exposure
70
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 39%
🔄 Reverse Split model est. 40%
• 50-day avg $1.52 approaching $1 threshold
• 9 months cash with weak price
📜 Warrant Exercise model 40%
• Significant warrants: 21% of shares outstanding
• Elevated warrant risk score (70/100)
💰 Capital Raise model 35%
• Under 12 months cash (9mo)
• Active shelf registration ($1000M, 216% of market cap)
🔔 Track AUTL — Get forecast alerts →

Market Data

Market Cap$463.12M
Shares Outstanding266.16M
Float33.90M
Cash$171.41M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore90/100DilutionWatch score record
Shares Outstanding266.16MVerified float table or market cache
Public Float33.90MVerified float table or market cache
Market Cap$463.12MMarket data cache
Cash Runway9.2 monthsDilutionWatch score inputs
Shelf Capacity$1.00BSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants56.50MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 3 1, FORM 4 2, S-3 2, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 4.8% shares (2026Q1 vs prior)
84 institutional holders · 138.26M shares
#1 MAK CAPITAL ONE LLC 33.62M shares
#2 Blackstone Inc. 20.49M shares
#3 Syncona Portfolio Ltd 16.64M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest8.40M
Days to Cover5.7
% of Float24.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-27
Form 4 INSIDER TRANSACTION 2026-09-02
Form 4 INSIDER TRANSACTION 2026-09-01
S-3 SHELF 2026-04-13
S-3 SHELF 2026-04-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual AUTL Dilution Snapshot

Autolus Therapeutics plc (AUTL) has a DilutionScore of 90/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

AUTL's DilutionScore is currently 90/100 (Critical risk), with 2 score changes tracked over 89 days. The score improved from 83/100 (Critical risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202690/100CRITICAL16 days
Sep 16 – Sep 27, 202683/100CRITICAL12 days
Jul 16 – Sep 15, 202684/100CRITICAL61 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track AUTL Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment AUTL files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking AUTL — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AUTL
AUTL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.